CS 4771Alternative Names: CS-4771
Latest Information Update: 01 Jun 2016
At a glance
- Originator Daiichi Sankyo Company
- Class Antibacterials
- Mechanism of Action Toll-like receptor 4 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Sepsis
Most Recent Events
- 27 May 2014 Discontinued - Phase-I for Sepsis in Japan (IV)
- 21 May 2010 Phase-I clinical trials in Sepsis in Japan (IV)